论文部分内容阅读
本文探讨术前化疗与手术时期选择的肾母细胞瘤最佳治疗方案。结果表明,标准化疗组与改良化疗组全瘤切除率分别为:69.2%、93.5%。术前化疗可有效提高肾母细胞瘤患儿术后存活率,但全瘤切除是保障患儿长期存活的基本条件,术前化疗与手术时期的选择对肾母细胞瘤患儿无瘤存活率具有重要意义。
This article discusses the preoperative chemotherapy and surgery during the selection of the best treatment of nephroblastoma. The results showed that the standard chemotherapy group and modified chemotherapy group total tumor resection rate were: 69.2%, 93.5%. Preoperative chemotherapy can effectively improve the survival rate of children with nephroblastoma, but the whole tumor excision is to protect the basic conditions for long-term survival of children, preoperative chemotherapy and surgical choice of tumor-free survival rate of children with nephroblastoma It is of great significance.